Track newly listed healthcare and biotech companies, their IPO performance, and market focus — all in one place.
| Company | Ticker | IPO Date | Amount Raised | Focus Area | Summary |
|---|---|---|---|---|---|
| GeneCure Therapeutics | GNCR | January 18, 2025 | $180M | Rare Genetic Diseases | IPO proceeds fund next-gen gene therapies for ultra-rare disorders with no approved treatments. |
| OncoNova Bio | ONVB | February 25, 2025 | $250M | Oncology | Developer of targeted small molecules for resistant solid tumors, expanding Phase II trials post-IPO. |
| ImmunoNext Inc. | IMNX | March 10, 2025 | $300M | Immuno-oncology | Emerging player in T-cell therapies for difficult-to-treat cancers, using novel bispecific antibodies. |
| NeuroSpark Health | NSPK | April 5, 2025 | $120M | Neurology | Focused on neurodegenerative diseases, advancing a lead compound for ALS and Parkinson’s symptoms. |
| CardioNova | CDNV | May 22, 2025 | $200M | Cardiology | Developing RNA-based treatments for heart failure and other chronic cardiovascular conditions. |